Lodaer Img

OralBLU™ Theranostics

Diagnose Early, Intercept Biologically, Act Decisively!
Oral Theranostics represents a Paradigm shift in Early Oral Cancer Detection & Biological Interception at the Cellular level.

OralBLU™ is not just a device. It is a clinical intelligence platform that detects, interprets, and intercepts oral pathology before it becomes irreversible.

Why Early Oral Cancer Detection Needs a New Language?
  • Conventional oral examination depends only on what the naked eye can see!
  • Unfortunately Cancer biology begins long before the lesions become visible intraorally.
  • OralBLU™ addresses this diagnostic blind spot by integrating state-of-the-art optical diagnostics followed by Advanced Photomedicine comprising of targeted PBM and precision PDT.
Why OralBLU™ Belongs to Every Modern Dental Clinic

Why Choose OralBLU™

1.

Transforms dentists into first-line oral cancer interceptors

2.

Enables early, Non-invasive Biological intervention

3.

Creates measurable clinical differentiation and patient trust

DNA Ploidy Kits

Charge per kit INR 4500 (including DNA analysis and reporting)

Legal Disclaimer:
This website only accepts DNA Kit orders to help doctors & patients solely on behalf of DNA Wellness Limited.

All DNA analysis and reporting are performed exclusively by the DNA Wellness Lab, and the report will be issued directly to the patient. OralBlue™ has no role, control, or responsibility in the testing process, report accuracy, interpretation, or legal validity.
There is no privity of contract between OralBlue™ and the patient. Any queries, claims, or concerns regarding the DNA test, report, interpretation, or legal aspects must be addressed directly to DNA Wellness Limited and/or the DNA Wellness Lab.

Legal Consent: By proceeding with this order, the doctor/patient hereby legally acknowledge and agree to the above terms.

High-Risk Zone Coverage

Lateral tongue, ventral tongue, floor of the mouth, retromolar trigone,
Oro-Pharyngeal sphincter etc scanned in paper close proximity.

Signal Fidelity Improvement

Reduction in Photon Scatter compared to extraoral Fluorescence systems.

Clinical Adoption Satisfaction

Dentists reporting OralBLU™ as indispensable for routine oral screening.

*Metrics represent system performance observed during controlled
‘In-clinic’ use & early stage testings. Not intended as diagnostic claims.
OralBLU™

Gallery

OralBLU™
Testimonials

Feedback From Our Clients

"With over a decade of clinical practice, early detection has always been my priority. Using OralBLU™ has significantly enhanced my ability to identify pre-cancerous changes at an early stage. It has added a new level of confidence and precision to my patient care.”

Image

Dr. C.P.John

"As a mid-career clinician in Pune, I strongly believe that adaptability is key to better patient care. Integrating OralBLU™ into my practice has allowed me to upgrade my diagnostic approach, especially for early pre-cancerous changes. It has added precision, confidence, and a higher standard of care for my patients."

Image

Dr. Saumil Mogre

"As a clinician committed to excellence in patient care, I value technologies that truly enhance early diagnosis. OralBLU™ has added clarity and confidence to my approach in identifying pre-cancerous changes, allowing me to deliver a higher standard of preventive care to my patients."

Image

Dr. Manasvi Behl

FAQ's

Frequently Asked Questions

Oral cancer and potentially malignant disorders are most frequently seen on the lateral borders of the tongue, floor of the mouth, buccal mucosa, gingiva, and soft palate.
Many of these changes are subtle in early stages and may appear clinically normal under routine white-light examination.

Traditional fluorescence systems are often:
•Large and non-portable
•Expensive and infrastructure-dependent
•Limited to screening alone
 
OralBLU™ is a compact, chairside, and workflow-friendly, fluorescence-based diagnostics which does not disrupt routine dental practice, whilst making early detection possible.

OralBLU™ uses intraoral optical scanning with true tissue proximity, allowing access to high-risk zones where early carcinogenesis  begins, way beyond the limits of white light and external fluorescence.

Follow-up scans track fluorescence normalization and metabolic recovery, transforming screening into a continuous biological monitoring system.

OralBLU™ is designed for:
•General dentists
•Oral medicine specialists
•Oral surgeons
•Institutions and cancer-screening programs
 
It is for all clinicians who want to move beyond passive observation and adopt a proactive, evidence-based approach to oral cancer detection and its early reversal.

OralBLU™ follows a Scan → Stratify → Intercept → Monitor approach, enabling early oral cancer interception within the dental operatory.

It also allows the Clinician to track the changes & monitor improvements induced by PBM / PDT

It reveals loss of autofluorescence, altered epithelial metabolism, and early dysplastic signaling — changes that are invisible under white light.

Yes. OralBLU™ allows a seamless transition from diagnosis to targeted PBM and PDT, delivered precisely to biologically altered tissue.